Cargando…
Tocilizumab as a promising agent against COVID-19: Issues and challenges
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548894/ https://www.ncbi.nlm.nih.gov/pubmed/34759997 http://dx.doi.org/10.4103/jrms.JRMS_524_20 |
| _version_ | 1784590680722505728 |
|---|---|
| author | Dastan, Farzaneh Tabarsi, Payam Abedini, Atefeh Saffaei, Ali |
| author_facet | Dastan, Farzaneh Tabarsi, Payam Abedini, Atefeh Saffaei, Ali |
| author_sort | Dastan, Farzaneh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8548894 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85488942021-11-09 Tocilizumab as a promising agent against COVID-19: Issues and challenges Dastan, Farzaneh Tabarsi, Payam Abedini, Atefeh Saffaei, Ali J Res Med Sci Letter to Editor Wolters Kluwer - Medknow 2021-09-30 /pmc/articles/PMC8548894/ /pubmed/34759997 http://dx.doi.org/10.4103/jrms.JRMS_524_20 Text en Copyright: © 2021 Journal of Research in Medical Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letter to Editor Dastan, Farzaneh Tabarsi, Payam Abedini, Atefeh Saffaei, Ali Tocilizumab as a promising agent against COVID-19: Issues and challenges |
| title | Tocilizumab as a promising agent against COVID-19: Issues and challenges |
| title_full | Tocilizumab as a promising agent against COVID-19: Issues and challenges |
| title_fullStr | Tocilizumab as a promising agent against COVID-19: Issues and challenges |
| title_full_unstemmed | Tocilizumab as a promising agent against COVID-19: Issues and challenges |
| title_short | Tocilizumab as a promising agent against COVID-19: Issues and challenges |
| title_sort | tocilizumab as a promising agent against covid-19: issues and challenges |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548894/ https://www.ncbi.nlm.nih.gov/pubmed/34759997 http://dx.doi.org/10.4103/jrms.JRMS_524_20 |
| work_keys_str_mv | AT dastanfarzaneh tocilizumabasapromisingagentagainstcovid19issuesandchallenges AT tabarsipayam tocilizumabasapromisingagentagainstcovid19issuesandchallenges AT abediniatefeh tocilizumabasapromisingagentagainstcovid19issuesandchallenges AT saffaeiali tocilizumabasapromisingagentagainstcovid19issuesandchallenges |